Canada

OEG Retail Cannabis and Four20 acquired the shops

With Syndicate, patients without insurance can access a catalogue of cannabis products, formats and brands at a competitive price

Cybin will pay Mindset an initial US$500K and 'development milestone payments' that could potentially total US$9.5M afterward

Kaya Cast is a podcast intended to help equip dispensaries with valuable tools and resources

Non-profit says Canada needs to make room for healthcare innovation with respect to psychedelic therapies

Neurology Centre of Toronto in Forest Hill expands its therapy catalogue

The company also announced the release of its first battery accessory and live resin vape cartridge Tribal G Mind in Ontario

Acquisition will expand Freedom's production capacity and lower its production costs

Campbell Becher joined the board of directors since June 16

New collaborative product line will launch this fall across the U.S.

Cannabis and SNDL have a joint agreement of exporting 1,000 kilograms of pot for processing and distribution in the Israeli market

Company considers patent to be significant achievement for R&D department

Study will evaluate psilocybin efficacy in healthcare workers with mental health challenges related to pandemic

RDARS' autonomous robotic systems provide situational awareness in a fashion that's both cost effective and reliable

Film screening was followed by audience Q&A session hosted by director

New clinical research will assess efficacy of IV formulation for the treatment of strokes

Company believes it has completed the largest mushroom harvest Canada has ever seen

New retail outlet said to be first one located in a major transportation hub around the globe

The collective is free of charge and has onboarded over 180 retailers to date

Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada

Clinical trial will be conducted as part of the ATMA Journey Centre's psychedelic-assisted therapist training program

Discovery of new drugs follows company decision to extend research outside of tryptamine class, i.e. psilocybin and DMT

Falko Regional Aircraft is an asset manager and aircraft leaser and its team has a considerable track record of selling aircraft.

First novel psilocybin compound to commence clinical development marks 'tremendous milestone' for biotechnology company

Application follows successful pre-clinical animal studies at the University of Arkansas

Novel proprietary psychedelic molecule continues to demonstrate potential for treating cocaine dependency

The company also released 7 new products under its Tilray and Aphria brands

Rise & Shine CBD Drops will initially be available in British Columbia followed by national distribution this fall

Cannabinoid tablet supplier expands its Canadian distribution network

Biotechnology organization will also supply LaNeo product to Australian research institute for clinical trial

Tilray's products are now approved by the Polish Ministry of Health

The partnership started in 2018

The company said there was a significant downturn in the California and Oregon markets

Company still expects to observe revenue growth for the remainder of 2022

Rejuvenate helps with rebuilding, restoring and rejuvenating the muscular wear and tear from aging or other medical conditions.

Vancouver producer to supply synthetic psychedelic compounds to designated investigators and companies

Revenue this quarter was 70% greater than the previous highest quarter

Appointments at the distribution centres will also be cancelled and its Customer Care Centre will be closed

The export approval includes 7,100 kilograms of cannabis in total

Darren Karasiuk was the previous CEO of Nova Cannabis